Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The ... - Yahoo Finance
| 095700 Stock | KRW 5,880 230.00 4.07% |
About 55% of Genexine's investors are presently thinking to get in. The analysis of current outlook of investing in Genexine suggests that some traders are interested regarding Genexine's prospects. The current market sentiment, together with Genexine's historical and current headlines, can help investors time the market. In addition, many technical investors use Genexine stock news signals to limit their universe of possible portfolio assets.
Genexine |
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The ... Yahoo Finance
Read at news.google.com
 |
Genexine Fundamental Analysis
We analyze Genexine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genexine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genexine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Genexine is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Genexine Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genexine stock to make a market-neutral strategy. Peer analysis of Genexine could also be used in its relative valuation, which is a method of valuing Genexine by comparing valuation metrics with similar companies.
Peers
Genexine Related Equities
| 086900 | Medy Tox | 2.17 | ||||
| 036200 | UNISEM | 1.65 | ||||
| 011390 | Busan Industrial | 0.89 | ||||
| 267250 | Hyundai Heavy | 0.62 | ||||
| 133820 | Fine Besteel | 0.71 | ||||
| 133820 | Finebesteel | 0.71 | ||||
| 012450 | Hanwha Aerospace | 11.00 |
Complementary Tools for Genexine Stock analysis
When running Genexine's price analysis, check to measure Genexine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genexine is operating at the current time. Most of Genexine's value examination focuses on studying past and present price action to predict the probability of Genexine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genexine's price. Additionally, you may evaluate how the addition of Genexine to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |